Abstract
A greater understanding of the factors and pathways controlling angiogenesis in tumours has allowed the development of a number of agents that selectively inhibit the pathways mediating that activity. The results to date of clinical trials with such agents and future research opportunities are reviewed. Copyright © 2009 Multimed Inc.
Author supplied keywords
Cite
CITATION STYLE
APA
Hirte, H. W. (2009). Novel developments in angiogenesis cancer therapy. Current Oncology. Multimed Inc. https://doi.org/10.3747/co.v16i3.444
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free